These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30036933)

  • 1. Lecture 2-What Is a Formulary, Anyway? (Or the Cliff Notes Version of Drug Stewardship and Expense Control).
    Parrish RH
    Pharmacy (Basel); 2018 Jul; 6(3):. PubMed ID: 30036933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
    Fry RN; Avey SG; Sullivan SD
    Value Health; 2003; 6(5):505-21. PubMed ID: 14627057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
    Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
    Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that influence prescribing decisions.
    Schumock GT; Walton SM; Park HY; Nutescu EA; Blackburn JC; Finley JM; Lewis RK
    Ann Pharmacother; 2004 Apr; 38(4):557-62. PubMed ID: 14966259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
    Weekes LM; Day RO
    Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From a to z: medication cost-management strategies for disproportionate share hospitals.
    Henry A; Erowele GI; Ndefo UA; Milton-Brown J; Anassi E; Green W; Alvidrez A; Okpara AU
    Am Health Drug Benefits; 2011 May; 4(3):172-80. PubMed ID: 25126349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert systems. Assisting formulary decision making in the ambulatory setting.
    Nash D; Windt PE; Peterson AM
    Pharmacoeconomics; 1994 Nov; 6(5):478-9. PubMed ID: 10155275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.
    Shalansky SJ; Virk R; Ackman M; Jackevicius C; Kertland H; Tsuyuki R; Humphries K;
    Can J Cardiol; 2003 Feb; 19(2):173-9. PubMed ID: 12601443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INTEGRATING HEALTH TECHNOLOGY ASSESSMENT PRINCIPLES IN FORMULARY MANAGEMENT.
    Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):81-7. PubMed ID: 27001376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formularies in integrated health systems: Sharp HealthCare.
    Rizos AL; Levy E; Furnier J; Crowley K
    J Healthc Resour Manag; 1996 Sep; 14(7):14-9. PubMed ID: 10161585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Is a Formulary, Anyway? Part 2.
    Parrish RH
    Pharmacy (Basel); 2018 Jul; 6(3):. PubMed ID: 30041407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harvey A. K. Whitney lecture. Interdependence in pharmacy: risks, rewards, and responsibilities.
    Zilz DA
    Am J Hosp Pharm; 1990 Aug; 47(8):1759-65. PubMed ID: 2389781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formularies in integrated health systems: Sharp HealthCare.
    Rizos AL; Levy E; Furnier J; Crowley K
    Am J Health Syst Pharm; 1996 Feb; 53(3):274-8. PubMed ID: 8808022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of pharmacoeconomics to formulary management in a health system setting.
    Studdert AL; Gong CL; Srinivas S; Chin AL; Deresinski S
    Am J Health Syst Pharm; 2019 Feb; 76(6):381-386. PubMed ID: 31361838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolving use of cost-effectiveness analysis in formulary management within the Department of Veterans Affairs.
    Aspinall SL; Good CB; Glassman PA; Valentino MA
    Med Care; 2005 Jul; 43(7 Suppl):20-6. PubMed ID: 16056005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.